Key facts
- Notable investors include Shanghai Healthcare Capital, Shanghai Shangshi Capital Management, ShareLink Capital, Sunland Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Anhui Qiarui Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Anhui Qiarui Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anhui Qiarui Biotechnology
Developer of blood purification medical consumables intended for medical institutions, clinical treatment departments, and healthcare providers. The company develops Class III blood purification consumables and a perfusion device, thereby enabling users to perform controlled removal of selected blood components and support refined treatment processes.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Anhui Qiarui Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anhui Qiarui Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anhui Qiarui Biotechnology in its N-PORT filings yet. We sweep new filings monthly.